Boston Scientific (MEX:BSX) Common Stock: MXN307 Mil (As of Mar. 2026)


MEX:BSX Boston Scientific Corp MEX:BSX
85 GF Score
Price MXN778.00
GF Value MXN1,851.53
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Boston Scientific Common Stock?

Boston Scientific MEX:BSX -0.51% 85 Common Stock is MXN307 Mil as of Mar. 2026. GuruFocus rates MEX:BSX with a GF Score™ of 85/100 and a GF Value™ of MXN1,851.53 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Boston Scientific's quarterly common stock declined from Sep. 2025 (MXN312 Mil) to Dec. 2025 (MXN306 Mil) but then increased from Dec. 2025 (MXN306 Mil) to Mar. 2026 (MXN307 Mil).

Boston Scientific's annual common stock increased from Dec. 2023 (MXN289 Mil) to Dec. 2024 (MXN355 Mil) but then declined from Dec. 2024 (MXN355 Mil) to Dec. 2025 (MXN306 Mil).

Boston Scientific Common Stock Historical Data

* Premium members only.

The historical data trend for Boston Scientific's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Boston Scientific Common Stock Chart

Boston Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 348.74 331.43 288.56 354.55 306.10

Boston Scientific Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 347.79 320.10 311.85 306.10 306.56
MEX:BSX
85GF Score
Boston Scientific Corp MEX:BSX
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Boston Scientific Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of MXN307 Mil mean?
Boston Scientific (MEX:BSX) has a Common Stock of MXN307 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Boston Scientific and its competitors.
Is Boston Scientific's Common Stock too high?
Boston Scientific's current Common Stock is MXN307 Mil. Overall, Boston Scientific has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Boston Scientific's Common Stock compare to EW and GEHC?
Boston Scientific's Common Stock of MXN307 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Devices & Instruments company?
A good Common Stock depends on the Medical Devices & Instruments industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Boston Scientific and its competitors. Boston Scientific's current Common Stock is MXN307 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Boston Scientific stock overvalued right now?
Based on GuruFocus' analysis, Boston Scientific (MEX:BSX) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN1,851.53, compared to a current price of MXN778.00 — trading 58% below its estimated fair value. The current Common Stock is MXN307 Mil. Boston Scientific's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Boston Scientific (MEX:BSX), the current Common Stock is MXN307 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Boston Scientific (MEX:BSX) Overvalued in 2026?

Based on GuruFocus' analysis, Boston Scientific stock appears to be undervalued. The current stock price of MXN778.00 is trading 58% below its estimated GF Value™ of MXN1,851.53. GuruFocus considers Boston Scientific to be Significantly Undervalued.

Key valuation signals for MEX:BSX:

  • Common Stock: MXN307 Mil
  • GF Value™: MXN1,851.53 vs. price of MXN778.00 (58% below fair value)
  • GF Score™: 85/100 with 1 warning sign

No single metric tells the full story. See the MEX:BSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Boston Scientific Business Description

Address 300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
85GF Score

Get the complete analysis for MEX:BSX

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN778.00
Price
MXN1,851.53
GF Value